patent/CN-103450348-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450348-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_327804b51d47ff6afc403138b838f3f5
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate	2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4e7a20cb619f94c03496d9ffeab324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b80782bbc97122dc1cf1dd2086f2df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9fd8ca1335ed30fc2c263424b82766d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5797d6b6c82d8133103488d945fa88be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fdc098f2db42eafeac299f24755542c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73dca7d7264f10eda6f43797ce3af5dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9293547bc2acb33fe60766746d2870a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d181bff3708a6aa93c5060dceecf1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abdd5b25c1715679d2b2b7d42438c27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2bb9dccd20554e4e9ca65842aa5fb5a
publicationDate	2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-103450348-A
titleOfInvention	A kind of erythropoietin mimic peptide, its preparation method and application
abstract	The present invention relates to the erythropoietin mimetic peptide represented by formula (I) and its use. The erythropoietin mimetic peptide, or a pharmaceutically acceptable salt thereof, can be used as a substitute for erythropoietin in medicines for preventing and/or treating diseases and/or symptoms related to EPO or EPO receptor low activity use.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085653-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106967149-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105837681-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085654-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608911-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109336963-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479592-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014194835-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554394-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554395-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554395-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109336963-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317217-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085653-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608912-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085654-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019085366-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105153293-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608906-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105153293-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105837681-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608912-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317217-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554394-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105367629-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106608911-B
priorityDate	2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101553242-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101443351-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164043950 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163516435 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465092917 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465855604

Total number of triples: 58.